These results indicated that both RIPK3 and MLKL were differentially detected in human CCA primary tissues, but only MLKL was significantly upregulated in tumor tissues in which high MLKL expression was associated with poor survival rates in CCA patients. The gene discussed is RIPK3; the disease is cholangiocarcinoma.